Author

Shila Kandel

University of Arkansas for Medical Sciences

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adrian R. KraineriD· 1 shared Israt Jahan MuktaiD· 1 shared Md Mahbub Hasan· 1 shared Md Rafikul Islam· 1 shared Mohammad Alinoor RahmaniD· 1 shared Naomi McNaughton· 1 shared Omar Ibrahim Abdel-WahabiD· 1 shared Panagiotis TsakiroglouiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrian R. KrainerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction

Md Rafikul Islam, Preeti Nagar, Naomi McNaughton, Shabiha Afroj Heeamoni, Md Mahbub Hasan, Shila Kandel, Israt Jahan Mukta, Panagiotis Tsakiroglou, William Brian Dalton, Omar Ibrahim Abdel-Wahab, Adrian R. Krainer, Mohammad Alinoor Rahman

This study identifies splicing dysregulation in SF-mutated cancers and demonstrates that antisense oligonucleotides can correct aberrant splicing and restore tumor suppressor function.

bioRxiv · Jan 8, 2026Cancer Biology